NewsNovo
Boston Scientific (BSX) has dropped roughly 58% from its 52-week peak to trade near $44.98, and selling a cash-secured put at the $30 strike expiring September 17, 2027 generates about $135 in premium per contract.
Layered onto the roughly 3.9% T-bill yield on the $3,000 in collateral, the blended annualized return comes to about 8.3%.
The complication: a cybersecurity incident that struck in August 2026 disrupted global order processing and shipping, and Boston Scientific said on September 8 the event is likely to have a material impact on third-quarter and full-year 2026 results without putting a figure on it.
The case for taking the trade Roughly 75% of Boston Scientific's revenue comes from businesses outside its two troubled segments, WATCHMAN and electrophysiology.
Keep reading